|Articles|July 1, 2011
- BioPharm International-07-01-2011
- Volume 24
- Issue 7
BioPharm International, July 2011 Issue (PDF)
Using Blow-Fill-Seal Technology
Advertisement
Articles in this issue
over 14 years ago
Impact of cGMP on Supply Chainover 14 years ago
Legislation v. Litigationover 14 years ago
The Status of the DNA Vaccine Fieldover 14 years ago
Biotech Posts Strong Gainsover 14 years ago
Biopharmaceutical Manufacturing Using Blow–Fill–Seal Technologyover 14 years ago
Offsetting Budget Cutsover 14 years ago
FDA and Manufacturers Ponder Biosimilars PathwayNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
